Systemic Antisense-Mediated Exon Skipping in Mouse Models for Duchenne Muscular Dystrophy

被引：0
|
作者：
Aartsma-Rus, Annemieke [1 ]
Heemskerk, Hans [1 ]
De Winter, Christa [1 ]
Van Putten, Maaike [1 ]
Janson, Anneke [2 ]
Verschuuren, Jan [1 ]
Den Dunnen, Johan [1 ]
Van Deutekom, Judith [2 ]
Van Ommen, Gert-Jan [1 ]
机构：
[1] Leiden Univ, Med Ctr, Leiden, Netherlands
[2] Prosensa Therapeut, Leiden, Netherlands
来源：
MOLECULAR THERAPY | 2009年 / 17卷
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
425
引用
收藏
页码：S166 / S166
页数：1
相关论文
共 50 条
  • [31] Antisense-mediated modulation of splicing Therapeutic implications for duchenne muscular dystrophy
    Aartsma-Rus, Annemieke
    RNA BIOLOGY, 2010, 7 (04) : 453 - 461
  • [32] Exon-Skipping in Duchenne Muscular Dystrophy
    Takeda, Shin ichi
    Clemens, Paula R.
    Hoffman, Eric P.
    JOURNAL OF NEUROMUSCULAR DISEASES, 2021, 8 : S343 - S358
  • [33] The Future of Exon Skipping for Duchenne Muscular Dystrophy
    Aartsma-Rus, Annemieke
    HUMAN GENE THERAPY, 2023, 34 (9-10) : 372 - 378
  • [34] Exon skipping therapy for Duchenne muscular dystrophy
    Kole, Ryszard
    Krieg, Arthur M.
    ADVANCED DRUG DELIVERY REVIEWS, 2015, 87 : 104 - 107
  • [35] Cell-mediated exon skipping for the therapy of Duchenne muscular dystrophy
    Cossu, Giulio
    HUMAN GENE THERAPY, 2018, 29 (07) : A4 - A4
  • [36] DEVELOPMENT OF SYSTEMIC ANTISENSE TREATMENT IN DYSTROPHIC MOUSE MODELS FOR DUCHENNE MUSCULAR DYSTROPHY
    Aartsma-Rus, Annemieke
    de Winter, Christa
    van Putten, Maaike
    Karnaoek, Tatyana
    van Deutekom, Judith
    van Ommen, Gert-Jan
    NUCLEIC ACID THERAPEUTICS, 2011, 21 (05) : A2 - A2
  • [37] Development of systemic antisense treatment in dystrophic mouse models for Duchenne muscular dystrophy
    Aartsma-Rus, A. M.
    Tanganyika-de Winter, C. L.
    van Putten, M.
    Karnaoek, T.
    van Deutekom, J. C. T.
    van Ommen, G. J. B.
    NEUROMUSCULAR DISORDERS, 2011, 21 (9-10) : 703 - 703
  • [38] Targeting a Novel Site in Exon 51 with Antisense Oligonucleotides Induces Enhanced Exon Skipping in a Mouse Model of Duchenne Muscular Dystrophy
    Oppeneer, Todd
    Qi, Yulan
    Henshaw, Joshua
    Larimore, Kevin
    Melton, Andrew
    Puolivali, Jukka
    Carter, Caitlyn
    Fant, Pierluigi
    Brennan, Sebastian
    Wetzel, Laura A.
    Sigg, Monika A.
    Crawford, Brett E.
    Magat, Jenna
    Froelich, Steven
    Woloszynek, Josh C.
    O'Neill, Charles A.
    NUCLEIC ACID THERAPEUTICS, 2025,
  • [39] Exon skipping therapy for Duchenne muscular dystrophy - it takes more than an antisense oligonucleotide
    Aartsma-Rus, Annemieke
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [40] ANTISENSE-BASED EXON SKIPPING AS A THERAPY FOR DUCHENNE MUSCULAR DYSTROPHY, STATUS AND PROSPECTS
    van Ommen, G. -J.
    Aartsma-Rus, A.
    Evers, M.
    van Roon, W.
    'tHoen, P. -B.
    Kemaladewi, D.
    Verbeek, S.
    Yllmaz-Elis, S.
    Dauwerse, H.
    Lesnik-Oberstein, S.
    den Dunnen, J. T.
    Goemans, N.
    Tulinus, M.
    Verschuuren, J.
    de Kimpe, S.
    Campion, G.
    van Deutekom, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 7 - 7
12345